TABLE 4.
Apnea-Hypopnea Index, 10 Events per Hour Increment |
Percentage of Recording Time at <90% O2 Saturation, 10% Increment |
|||||
---|---|---|---|---|---|---|
n | Coefficient (95% CI) or OR (95% CI) | P Value | n | Coefficient (95% CI) or OR (95% CI) | P Value | |
| ||||||
Structural/imaging measures | ||||||
Primary variables | ||||||
RV systolic pressure, mm Hga | 157 | 0.84 (−01.92 to 3.59) | 0.55 | 153 | 2.49 (1.58 to 3.40) | <0.001 |
RV ejection fraction, %b | 135 | −2.09 (−3.93 to −0.24) | 0.027 | 133 | −0.94 (−1.47 to −0.40) | <0.001 |
Secondary variables | ||||||
Tricuspid annular plane systolic excursion, cma | 159 | −0.02 (−0.08 to 0.04) | 0.52 | 155 | −0.03 (−0.05 to −0.01) | 0.003 |
Global RV free wall peak longitudinal strain (3 segments), %a | 146 | 0.47 (−0.25 to 1.20) | 0.20 | 141 | 0.39 (0.12 to 0.65) | 0.004 |
Global RV free wall peak longitudinal strain (6 segments), %a | 144 | 0.40 (−0.18 to 0.97) | 0.18 | 139 | 0.26 (0.04 to 0.47) | 0.022 |
RV end-diastolic area, cm/m2a | 161 | 1.07 (−0.06 to 2.20) | 0.063 | 156 | 0.67 (0.29 to 1.05) | <0.001 |
RV fractional shortening, %a | 161 | −1.10 (−2.36 to 0.16) | 0.086 | 156 | −0.71 (−1.14 to −0.29) | 0.001 |
RV end-diastolic basal dimension, cma | 170 | 0.08 (−0.01 to 0.18) | 0.076 | 165 | 0.05 (0.02 to 0.08) | 0.001 |
RVD wall thickness, cma | 162 | 0.01 (−0.01 to 0.04) | 0.38 | 157 | 0.01 (0.00 to 0.02) | 0.018 |
RVOT velocity-time integral, cma | 167 | −0.41 (−1.03 to 0.21) | 0.19 | 164 | −0.20 (−0.41 to 0.02) | 0.076 |
RV end-diastolic volume index, mL/m2b | 135 | 2.94 (−4.14 to 10.03) | 0.41 | 133 | 3.86 (1.87 to 5.86) | <0.001 |
RV end-systolic volume index, mL/m2b | 135 | 3.99 (−2.71 to 10.68) | 0.24 | 133 | 3.77 (1.88 to 5.65) | <0.001 |
RV stroke volume index, mL/m2b | 135 | −1.04 (−2.68 to 0.60) | 0.21 | 133 | 0.10 (−0.40 to 0.59) | 0.70 |
RV mass, gb | 135 | 1.34 (−1.98 to 4.66) | 0.43 | 133 | 2.10 (1.19 to 3.02) | <0.001 |
RV peak global longitudinal systolic strain, %b | 110 | 0.94 (−0.01 to 1.89) | 0.052 | 108 | 0.24 (−0.03 to 0.52) | 0.076 |
Hemodynamic measures | ||||||
Primary variable | ||||||
Mean PA pressure (spontaneous breathing), mm Hgc | 176 | 1.12 (−0.72 to 2.95) | 0.23 | 171 | 1.86 (1.29 to 2.42) | <0.001 |
Secondary variables | ||||||
Mean RA pressure (spontaneous breathing), mm Hgc | 175 | 0.61 (0.02 to 1.20) | 0.042 | 170 | 0.19 (−0.02 to 0.39) | 0.076 |
Mean PCWP (a wave) (spontaneous breathing), mm Hgc | 175 | 0.23 (−0.43 to 0.90) | 0.49 | 170 | 0.28 (0.05 to 0.51) | 0.017 |
Cardiac output, L/minc | 176 | −0.19 (−0.37 to −0.02) | 0.029 | 171 | 0.00 (−0.06 to 0.06) | 0.97 |
Rest: cardiac index, L/min/m2c | 176 | −0.09 (−0.18 to −0.00) | 0.05 | 171 | 0.00 (−0.03 to 0.04) | 0.79 |
PVR (spontaneous breathing), WUc | 174 | 0.47 (0.01 to 0.94) | 0.047 | 169 | 0.36 (0.20 to 0.51) | <0.001 |
Electrophysiological measures | ||||||
Primary variable | ||||||
RV hypertrophyd | 177 | 1.08 (0.79 to 1.48) | 0.64 | 172 | 1.26 (1.11 to 1.44) | <0.001 |
Secondary variables | ||||||
Right bundle branch blockd | 177 | 1.05 (0.68 to 1.61) | 0.84 | 172 | 1.09 (0.96 to 1.24) | 0.20 |
Right-axis deviationd | 177 | 1.14 (0.88 to 1.48) | 0.32 | 172 | 1.10 (1.01 to 1.21) | 0.035 |
Models were adjusted for age, sex, race, body mass index, pulmonary hypertension medications, supplemental oxygen use, and diffusing capacity of the lungs for carbon monoxide.
Obtained from echocardiogram.
Obtained from cardiac magnetic resonance imaging.
Obtained from right heart catheterization.
Obtained from electrocardiography.
PA = pulmonary artery; PCWP = pulmonary capillary wedge pressure; PVR = pulmonary vascular resistance; RA = right atrial; RV = right ventricular; RVD = right ventricular diastolic; RVOT = right ventricular outflow tract.